Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Mar 15, 2022 4:10pm
135 Views
Post# 34516346

RE:RE:RE:RE:RE:RE:RE:RE:MTD

RE:RE:RE:RE:RE:RE:RE:RE:MTD

I think you are reading way to much into that as what that colloquialism means down here is that they aren't that AT ALL, not leaving the antithesis any room. As a lawyer would tell you, it s impossible to be definitive 100% unless you actually know, and I don't. I am guessing based on what I see, but I can't pretend to know 100% of what they do.


jfm1330 wrote: This sentence is really something. Think about it twice. It means that they are unscientific or unprofessionnal to some extent. Why would you invest in such a company or stay invested? And how can you expect such relatively unscientific or unprofessional people to promote the stock? How relatively unscientific people can be trusted to develop a valid drug that will end up as a commercial success? This board is totally lost in an irrational love/hate relation with this company. This little sentence is just a reflection of that. Half incompetent company will develop a great effective anti-cancer drug. Again. Think about it twice.
 

Wino115 wrote:

  They aren't that unscientific or unprofessional from what I can see.  





<< Previous
Bullboard Posts
Next >>